Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

9.66
+0.29003.09%
Post-market: 9.65-0.0100-0.10%19:56 EDT
Volume:1.75M
Turnover:16.79M
Market Cap:637.69M
PE:-2.57
High:10.10
Open:10.00
Low:9.21
Close:9.37
52wk High:16.19
52wk Low:5.46
Shares:66.01M
Float Shares:57.34M
Volume Ratio:0.85
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7652
EPS(LYR):-3.7593
ROE:-137.63%
ROA:-21.20%
PB:8.89
PE(LYR):-2.57

Loading ...

Top Premarket Gainers

MT Newswires Live
·
Aug 28

Regenxbio Climbs as New Director Buys Nearly $1 Million of Stock

Reuters
·
Aug 28

Regenxbio director buys $949.4K in common stock

TIPRANKS
·
Aug 28

Regenxbio Director Gregory Austin Ciongoli Acquires Common Shares Worth $952,001.59

Reuters
·
Aug 28

Regenxbio Director Gregory Austin Ciongoli Files Initial Beneficial Ownership Statement

Reuters
·
Aug 28

Regenxbio Inc. : H.c. Wainwright Cuts Target Price to $21 from $23

THOMSON REUTERS
·
Aug 25

Regenxbio Appoints Greg Ciongoli to Board of Directors

Reuters
·
Aug 25

Regenxbio Strengthens Board of Directors with Appointment of Greg Ciongoli

THOMSON REUTERS
·
Aug 25

Regenxbio Inc. : Clear Street Cuts Target Price to $32 from $45

THOMSON REUTERS
·
Aug 25

Regenxbio is Maintained at Outperform by Baird

Dow Jones
·
Aug 25

Regenxbio price target lowered to $32 from $45 at Clear Street

TIPRANKS
·
Aug 25

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Ansell (OtherANSLF)

TIPRANKS
·
Aug 25

Top Midday Decliners

MT Newswires Live
·
Aug 25

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

TIPRANKS
·
Aug 24

Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial

Dow Jones
·
Aug 24

Regenxbio Shares Down 25% Premarket After FDA Places Clinical Hold on Co's Gene Therapy for Hunter Syndrome

THOMSON REUTERS
·
Aug 24

Regenxbio reports FDA placed clinical hold on RGX-121

TIPRANKS
·
Aug 24

FDA Places Clinical Hold on Regenxbio RGX-121 Gene Therapy for Hunter Syndrome After Spine MRI Findings

Reuters
·
Aug 24

Regenxbio - Co and Ns Pharma Evaluating Additional Data for Rgx-121

THOMSON REUTERS
·
Aug 24

Regenxbio - FDA Places Clinical Hold on Rgx-121 After Spine Mri Findings

THOMSON REUTERS
·
Aug 24